down arrow

Mercury Labs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE947G01011
  • NSEID:
  • BSEID: 538964
INR
823.80
7.25 (0.89%)
BSENSE

Apr 11, 11:42 AM

BSE+NSE Vol: 1

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1 (-92.96%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

73.66%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Operating profit has grown by an annual rate -3.04% of over the last 5 years

 
2

Flat results in Dec 24

3

Stock is technically in a Bearish range

4

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 98 Cr (Micro Cap)

stock-summary
P/E

25.00

stock-summary
Industry P/E

27

stock-summary
Dividend Yield

0.43%

stock-summary
Debt Equity

0.04

stock-summary
Return on Equity

7.62%

stock-summary
Price to Book

1.90

Revenue and Profits (1 Year):
Net Sales:
20 Cr
(Quarterly Results - Dec 2024)
Net Profit:
1 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.43%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-18.52%
0%
-18.52%
1 Year
-11.61%
0.40%
-11.21%
2 Years
22.56%
1.22%
23.78%
3 Years
56.02%
2.26%
58.28%
4 Years
39.31%
1.67%
40.98%
5 Years
193.17%
3.34%
196.51%

Latest dividend: 3.5 per share ex-dividend date: Sep-20-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
4.52%
EBIT Growth (5y)
-3.04%
EBIT to Interest (avg)
5.26
Debt to EBITDA (avg)
0.89
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.42
Tax Ratio
27.84%
Dividend Payout Ratio
7.43%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.74%
ROE (avg)
10.73%
Valuation key factors
Factor
Value
P/E Ratio
25
Industry P/E
27
Price to Book Value
1.90
EV to EBIT
21.35
EV to EBITDA
13.23
EV to Capital Employed
1.86
EV to Sales
1.39
PEG Ratio
NA
Dividend Yield
0.43%
ROCE (Latest)
9.23%
ROE (Latest)
7.62%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Shah Dilip Ramanlal Huf (25.88%)

Highest Public shareholder

Rajeshri K Shah (2.2%)

Individual Investors Holdings

16.63%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 7.59% vs 9.05% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 138.00% vs 47.06% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "19.57",
          "val2": "18.19",
          "chgp": "7.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.98",
          "val2": "1.30",
          "chgp": "52.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.13",
          "val2": "0.15",
          "chgp": "-13.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.19",
          "val2": "0.50",
          "chgp": "138.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.12%",
          "val2": "7.15%",
          "chgp": "2.97%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -15.12% vs 3.55% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -66.53% vs -45.55% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "34.87",
          "val2": "41.08",
          "chgp": "-15.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.92",
          "val2": "4.15",
          "chgp": "-29.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.29",
          "val2": "0.18",
          "chgp": "61.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.84",
          "val2": "2.51",
          "chgp": "-66.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "8.37%",
          "val2": "10.10%",
          "chgp": "-1.73%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -6.44% vs 4.10% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -45.87% vs -28.16% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "54.44",
          "val2": "58.19",
          "chgp": "-6.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.90",
          "val2": "6.38",
          "chgp": "-23.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.42",
          "val2": "0.28",
          "chgp": "50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "2.03",
          "val2": "3.75",
          "chgp": "-45.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.00%",
          "val2": "10.96%",
          "chgp": "-1.96%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 0.31% vs 30.06% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 1.25% vs 56.74% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "75.56",
          "val2": "75.33",
          "chgp": "0.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "9.04",
          "val2": "8.56",
          "chgp": "5.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.38",
          "val2": "0.36",
          "chgp": "5.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "5.65",
          "val2": "5.58",
          "chgp": "1.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.96%",
          "val2": "11.36%",
          "chgp": "0.60%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
19.57
18.19
7.59%
Operating Profit (PBDIT) excl Other Income
1.98
1.30
52.31%
Interest
0.13
0.15
-13.33%
Exceptional Items
0.00
0.00
Standalone Net Profit
1.19
0.50
138.00%
Operating Profit Margin (Excl OI)
10.12%
7.15%
2.97%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 7.59% vs 9.05% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is 138.00% vs 47.06% in Sep 2024

Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
34.87
41.08
-15.12%
Operating Profit (PBDIT) excl Other Income
2.92
4.15
-29.64%
Interest
0.29
0.18
61.11%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.84
2.51
-66.53%
Operating Profit Margin (Excl OI)
8.37%
10.10%
-1.73%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -15.12% vs 3.55% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is -66.53% vs -45.55% in Sep 2023

Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
54.44
58.19
-6.44%
Operating Profit (PBDIT) excl Other Income
4.90
6.38
-23.20%
Interest
0.42
0.28
50.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
2.03
3.75
-45.87%
Operating Profit Margin (Excl OI)
9.00%
10.96%
-1.96%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -6.44% vs 4.10% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is -45.87% vs -28.16% in Dec 2023

Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
75.56
75.33
0.31%
Operating Profit (PBDIT) excl Other Income
9.04
8.56
5.61%
Interest
0.38
0.36
5.56%
Exceptional Items
0.00
0.00
Standalone Net Profit
5.65
5.58
1.25%
Operating Profit Margin (Excl OI)
11.96%
11.36%
0.60%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 0.31% vs 30.06% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 1.25% vs 56.74% in Mar 2023

stock-summaryCompany CV
About Mercury Laboratories Ltd stock-summary
stock-summary
Mercury Laboratories Ltd
Micro Cap
Pharmaceuticals & Drugs
Mercury Laboratories Limited, the registered partnership firm started its business activity in year 1962. Subsequently, the Company converted into Private Limited Company & incorporated in February, 1982. Later, it further converted into Limited Company in 1992 in Maharashtra. The Company is engaged in the business of Pharmaceutical items, medicinal drugs and formulations. It is a profit making and dividend paying public limited company.
Company Coordinates stock-summary
Company Details
1st Floor 18 Shreeji Bhuwan 51, Princess Street Mangaladas Rd Mumbai Maharashtra : 400002
stock-summary
Tel: 91-22-66372841
stock-summary
mllbrd@mwercurylabs.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai